Last reviewed · How we verify
Nefopam Injectable Solution
At a glance
| Generic name | Nefopam Injectable Solution |
|---|---|
| Sponsor | Saint-Joseph University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Sphenopalatine Block in Headache in Patients With Non-traumatic Subarachnoid Hemorrhage (NA)
- Nefopam Versus Ondansteron for Prevention of Post Spinal Shivering. (PHASE4)
- Comparison of Two Routes of Administration of a Multimodal Analgesic Protocol in Postoperative Cesarean Section (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |